← Back to headlines
Astrazeneca Exceeds Q1 Expectations Driven by Cancer Drug Sales
Astrazeneca reported first-quarter results that surpassed expectations, primarily due to robust sales of its cancer medications.
29 Apr, 13:18 — 29 Apr, 13:18
Sources
Showing 1 of 1 sources
